Autologous bone-marrow stem-cell transplantation for myocardial regeneration
- PMID: 12517467
- DOI: 10.1016/S0140-6736(03)12110-1
Autologous bone-marrow stem-cell transplantation for myocardial regeneration
Abstract
Implantation of bone-marrow stem cells in the heart might be a new method to restore tissue viability after myocardial infarction. We injected up to 1.5x10(6) autologous AC133+ bone-marrow cells into the infarct border zone in six patients who had had a myocardial infarction and undergone coronary artery bypass grafting. 3-9 months after surgery, all patients were alive and well, global left-ventricular function was enhanced in four patients, and infarct tissue perfusion had improved strikingly in five patients. We believe that implantation of AC133+ stem cells to the heart is safe and might induce angiogenesis, thus improving perfusion of the infarcted myocardium. See Commentary page 11
Comment in
-
Bone marrow transplantation for the heart: fact or fiction?Lancet. 2003 Jan 4;361(9351):11-2. doi: 10.1016/S0140-6736(03)12186-1. Lancet. 2003. PMID: 12517456 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
